Evidence map›Paper›PMID 21716072›Full record

ArticleAIDS (London, England)2011

Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3.

Michael H Chung, Kevin P McKenzie, Barbra A Richardson, Grace C John-Stewart, Robert W Coombs, Hugo De Vuyst, Julia W Njoroge, Evans Nyongesa-Malava, Samah R Sakr, Nelly R Mugo

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Michael H ChungDepartment of Global Health, University of Washington, Seattle, USA. mhchung@uw.edu
Kevin P McKenzie
Barbra A Richardson
Grace C John-Stewart
Robert W Coombs
Hugo De Vuyst
Julia W Njoroge
Evans Nyongesa-Malava
Samah R Sakr
Nelly R Mugo
University of Washington · USCentre International de Recherche sur le Cancer · FRFred Hutch Cancer Center · USKenyatta National Hospital · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
HAART Adherence Interventions in Africa: an RCTK23AI065222 · NIAID · UNIVERSITY OF WASHINGTON · PI CHUNG, MICHAEL HOONBAE · 2005 to 2009
$639k
NIAID NIH HHS 5K23AI065222-04NIAID NIH HHS AI27757NIAID NIH HHS K23 AI065222NIAID NIH HHS P30 AI027757NICHD NIH HHS 1K24HD054314-04NICHD NIH HHS K24 HD054314PHS HHS U62/CCU024512-04
6 · The paper itself

Abstract

objectiveTo determine the effect of cryotherapy on HIV-1 cervical shedding.

designProspective cohort study.

methodsFive hundred HIV-positive women enrolled at an HIV treatment clinic in Nairobi, Kenya were screened for cervical cancer. Women diagnosed with cervical intraepithelial neoplasia stage 2 or 3 (CIN 2/3) by histology were offered cryotherapy treatment. The first 50 women had cervical swabs taken at baseline and at 2 and 4 weeks following treatment. Swabs were analyzed for HIV-1 RNA and compared using General Estimating Equation (GEE) with binomial or Gaussian links.

resultsOf the 50 women enrolled, 40 were receiving antiretroviral therapy (ART) and 10 were not receiving ART at the time of cryotherapy and during study follow-up. Among all women, the odds of detectable cervical HIV-1 RNA did not increase at 2 weeks [odds ratio (OR) 1.18; 95% confidence interval (CI) 0.65-2.13] or 4 weeks (OR 1.29; 95% CI 0.71-2.33) following cryotherapy. Among 10 women not receiving ART, the OR of detectable shedding at 2 weeks was higher, but not statistically significant (OR 4.02; 95% CI 0.53-30.79; P = 0.2), and at 4 weeks remained unchanged (OR 1.00; 95% CI 0.27-3.74).

conclusionThere was no increase in detectable cervical HIV-1 RNA among HIV-positive women after cryotherapy. The risk of HIV-1 transmission after cryotherapy may not be significant, particularly among women already on ART at the time of cervical treatment. However, further investigation is needed among women not receiving ART.

Indexed as

CryotherapyHIV-1Virus SheddingAdultCohort StudiesFemaleHIV InfectionsHumansKenyaMiddle AgedNeoplasm StagingProspective StudiesRNA, ViralUterine Cervical DysplasiaUterine Cervical NeoplasmsRNA, Viral

Identifiers

PMID21716072
PMCPMC3248579
OpenAlexW2076471277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.